- Pr. Marina Cavazzana a présidé la session suivante :
The evolving role of sex, inflammation and aging in cancer immunotherapy
- Dr. Jean-Sébastien DIANA a présenté les travaux suivants:
– GMP-manufactured allogenic human T lymphoid progenitors (HTLP) promote early and sustained T-cell recovery after CD34+-selected haploidentical HSCT in SCID patients: Final results of the HTLP-SCID study
– Expanding access to haploidentical transplantation: Clinical feasibility of a centralized nationwide distribution model for fresh TCRa/b-depleted grafts in France
- Dr. Emmanuelle Six a présenté les travaux suivants :
Inflammation and Gene therapy
